AbbVie
ABBV
#30
Rank
HK$2.410 T
Marketcap
HK$1,364
Share price
2.37%
Change (1 day)
14.48%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

EPS for AbbVie (ABBV)

EPS in 2023 (TTM): HK$28.81

According to AbbVie's latest financial reports the company's current EPS (TTM) is HK$28.60. In 2022 the company made an earnings per share (EPS) of HK$51.73 an increase over its 2021 EPS that were of HK$50.40.

EPS history for AbbVie from 2011 to 2023

Annual EPS

Year EPS Change
2023 (TTM)HK$28.81-44.31%
2022HK$51.732.63%
2021HK$50.40125.21%
2020HK$22.38-45.69%
2019HK$41.2148.35%
2018HK$27.787.6%
2017HK$25.82-9.3%
2016HK$28.4715.48%
2015HK$24.65185.53%
2014HK$8.63-57.11%
2013HK$20.13-21.69%
2012HK$25.7155.73%
2011HK$16.51

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
HK$14.45-49.47%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$30.85 7.86%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$42.19 47.51%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$109.95 284.44%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$34.11 19.27%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$143.43 401.54%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$27.20-4.89%๐Ÿ‡ฌ๐Ÿ‡ง UK
HK$15.42-46.07%๐Ÿ‡ฌ๐Ÿ‡ง UK
HK$15.23-46.75%๐Ÿ‡บ๐Ÿ‡ธ USA